Diabetestechnologie (Update 2023)

This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps) and access to these technological innovations for people with diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Schütz-Fuhrmann, Ingrid, Rami-Merhar, Birgit, Fröhlich-Reiterer, Elke, Hofer, Sabine E., Tauschmann, Martin, Mader, Julia K., Resl, Michael, Kautzky-Willer, Alexandra, Winhofer-Stöckl, Yvonne, Laimer, Markus, Zlamal-Fortunat, Sandra, Weitgasser, Raimund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Leitlinien Für Die Praxis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132921/
https://www.ncbi.nlm.nih.gov/pubmed/37101025
http://dx.doi.org/10.1007/s00508-023-02165-9
Descripción
Sumario:This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps) and access to these technological innovations for people with diabetes mellitus based on current scientific evidence.

Ejemplares similares